临床儿科杂志 ›› 2016, Vol. 34 ›› Issue (8): 606-.doi: 10.3969/j.issn.1000-3606.2016.08.011

• 综合报道 • 上一篇    下一篇

兄弟同患遗传性肾性尿崩症 2 例报告并文献复习

刘子勤, 陈晓波, 宋福英, 邱明芳, 刘颖, 叶雪, 钱晔   

  1. 首都儿科研究所内分泌科(北京 100020)
  • 收稿日期:2016-08-15 出版日期:2016-08-15 发布日期:2016-08-15
  • 通讯作者: 陈晓波 E-mail:xiaobochen6362@163.com

Congenital nephrogenic diabetes insipidus: 2 cases report of brothers and review

LIU Ziqin, CHEN Xiaobo, SONG Fuying, QIU Mingfang, LIU Ying, YE Xue, QIAN Ye   

  1. Department of Endocrinology, Capital Institute of Pediatrics, Beijing 100020,China
  • Received:2016-08-15 Online:2016-08-15 Published:2016-08-15

摘要: 目的 加强对遗传性肾性尿崩症(CNDI)的认识。方法 回顾性分析2例同患CNDI的同胞兄弟的临床资料,并 复习相关文献。结果 2例同胞男性患儿,分别为6岁、 3岁,均有多饮多尿,持续低比重尿。一代基因测序发现AQP2基因第 254位精氨酸突变成组氨酸,为未报道的新型移码突变,导致AQP2蛋白延长。确诊后给予阿米洛利治疗,短期随访尿量减少, 无电解质紊乱。结论 基因检查可以帮助确诊CNDI,复方阿米洛利治疗有效。

Abstract: Objective  Congenital nephrogenic diabetes insipidus (CNDI) is a rare disease, the aim of this article is to help  better understanding of this disease. Methods The clinical features, genetic analysis and treatments of two siblings with CNDI  were retrospectively analyzed, and related literatures were reviewed. Results Both brothers had polydispia, polyuria and low  concentrate urine continuously, and they both had a mutation in AQP2 confirmmed with Sanger sequencing. This novel frame  shift mutation caused arginine of 254 to histidine, and prolonged AQP2 protein. Conclusions Gene analysis can help diagnosis  of CNDI. Amiloride is useful option for treatment.